Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.04.038 Cytoreductive Nephrectomy: To Whom and When?

被引：0

作者：

Mollica, Veronica ^{[1
]}

Rizzo, Alessandro ^{[1
]}

Massari, Francesco ^{[1
]}

机构：

[1] St Orsola Marcello Malpighi Hosp, Div Oncol, Bologna, Italy

来源：

EUROPEAN UROLOGY ONCOLOGY | 2020年 / 3卷 / 04期

关键词：

D O I：

10.1016/j.euo.2020.05.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：559 / 560

页数：2

共 50 条

[31] Reply to Benjamin Davies, Keith Kowalczyk RE: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041
Klaassen, Zachary
Catto, James W. F.
Vickers, Andrew J.
Cooperberg, Matthew R.
Kutikov, Alexander
[J]. EUROPEAN UROLOGY, 2022, 82 (01) : E12 - E12
[32] Re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015 Strategies for Effective Prehabilitation in Urologic Cancer
Ushida, Kenta
Shimizu, Miho
Momosaki, Ryo
[J]. EUROPEAN UROLOGY, 2021, 80 (06) : E139 - E140
[33] Re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Iyer, Gopa
Bochner, Bernard H.
Van Allen, Eliezer M.
Solit, David B.
Rosenberg, Jonathan E.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E56 - E57
[34] Re: Kristian D. Stensland, Harras Zaid, Mark Broadwin, et al. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2018.11.003
Moschini, Marco
Zamboni, Stefania
Mattei, Agostino
[J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (02): : 230 - 230
[35] Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006 Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Noel, Johanna
Huillard, Olivier
Goldwasser, Francois
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : E112 - E112
[36] Re: Evanguelos Xylinas, Michael Rink, Eugene K. Cha, et al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.052
Luo, Hao Lun
Chiang, Po Hui
[J]. EUROPEAN UROLOGY, 2012, 62 (05) : E92 - E93
[37] Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012
Kerkmeijer, Linda G. W.
Pos, Floris J.
van der Heide, Uulke A.
Israel, Bas
Draulans, Cedric
Haustermans, Karin
[J]. EUROPEAN UROLOGY, 2022, 81 (06) : E147 - E148
[38] Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84: 109-116
Zhao, Binghao
Xing, Hao
Ma, Wenbin
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E16 - E17
[39] Re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021
Singh, Kirti
Mandal, Swarnendu
Das, Manoj Kumar
Nayak, Prasant
Tripathy, Sambit
[J]. EUROPEAN UROLOGY, 2023, 83 (06)
[40] Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039
Stephan, Carsten
Cammann, Henning
Jung, Klaus
[J]. EUROPEAN UROLOGY, 2015, 68 (05) : E106 - E107

← 1 2 3 4 5 →